朱敦皖，1976年出生，籍貫安徽太湖，現任中國醫學科學院生物醫學工程研究所副所長、研究員、博士生導師。1994年考入四川大學化學纖維專業，1998年獲得學士學位。2002年在天津大學材料學專業攻讀碩士學位，從事生物材料研究。2005年在天津大學材料專業攻讀博士學位，從事生物材料研究。2012年10月至2013年10月美國明尼蘇達大學訪問學者。2008年7月升為助理研究員，2011年9月為副研究員，2018年9月為研究員。

針對腫瘤免疫治療存在的脫靶副作用及有限的患者響應率等關鍵問題，重點開展新型納米腫瘤疫苗、納米生物材料介導腫瘤免疫聯合治療和生物材料與腫瘤免疫微環境等研究。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Wang Nannan#, Zuo Yueyue#, Wu Shengjie, Huang Chenlu, Zhang Linhua*, and Zhu Dunwan*. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses. Acta Pharm Sin B. 2022;12(12):4486-4500. (IF=14.903)

2. Lu Yan, Gong Yonghua, Zhu Xianghui, Dong Xia*, Zhu Dunwan*, and Ma Guilei*. Design of Light-Activated Nanoplatform through Boosting "Eat Me" Signals for Improved CD47-Blocking Immunotherapy. Advanced Healthcare Materials. 2022, 11(10):e2102712. (IF=11.092)

3. Li Qianqian, Shi Zhaoqing, Zhang Fan, Zeng Weiwei, Zhu Dunwan*, and Mei Lin*. Symphony of nanomaterials and immunotherapy based on the cancer?immunity cycle. Acta Pharmaceutica Sinica B. 2022, 12(1):107-34. (IF=14.903)

4. Huang Chenlu, Zhang Li, Guo Qing, Zuo Yueyue, Wang Nannan, Wang Hai, Kong Deling*, Zhu Dunwan*, and Zhang Linhua*. Robust Nanovaccine Based on Polydopamine-Coated Mesoporous Silica Nanoparticles for Effective Photothermal-Immunotherapy Against Melanoma. Advanced Functional Materials. 2021, 31(18):2010637. (IF 18.808)

5. Zhang Zhiming#, Huang Chenlu#, Zhang Li, Guo Qing, Qin Yu, Fan Fan, Li Boxuan, Xiao Bao, Zhu Dunwan*, and Zhang Linhua*. pH-Sensitive and Bubble-Generating Mesoporous Silica-Based Nanoparticles for Enhanced Tumor Combination Therapy. Acta Pharmaceutica Sinica B. 2021, 11(2):520-33. (IF=11.614)

6. Zhang Linhua, Wu Shengjie, Qin Yu, Fan Fan, Zhang Zhiming, Huang Chenlu, Ji Weihang, Lu Lu, Wang Chun, Sun Hongfan, Leng Xigang, Kong Deling, and Zhu Dunwan*. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy. Nano Letters. 2019, 19(7): 4237-49. (IF=11.238, 副封面論文)

7. Zhu Dunwan, Hu Chunyan, Fan Fan, Qin Yu, Huang Chenlu, Zhang Zhiming, Lu Lu, Wang Hai, Sun Hongfan, Leng Xigang, Wang Chun, Kong Deling, and Zhang Linhua*. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination. Biomaterials. 2019, 206:25-40. (IF=10.317)

8. Huang Chenlu#, Zhang Zhiming#, Guo Qin, Zhang Li, Fan Fan, Qin Yu, Wang Hai, Zhou Sheng, Ou-Yang Wenbin, Sun Hongfan, Leng Xigang, Pan Xiangbin, Kong Deling, Zhang Linhua*, and Zhu Dunwan*. A Dual-Model Imaging Theragnostic System Based on Mesoporous Silica Nanoparticles for Enhanced Cancer Phototherapy. Advanced Healthcare Materials. 2019, 8(19):e1900840. (IF=7.367)

9. Zhang Linhua#, Qin Yu#, Zhang Zhiming, Fan Fan, Huang Chenlu, Lu Li, Wang Hai, Jin Xu, Zhao Hanxue, Kong Deling, Wang Chun, Sun Hongfan, Leng Xigang, and Zhu Dunwan*. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination. Acta Biomaterialia. 2018, 75:371-85. (IF=6.638)

10. Zhu Dunwan, Tao Wei, Zhang Hongling, Liu Gan, Wang Teng, Zhang Linhua, Zeng Xiaowei*, and Mei Lin*. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomaterialia. 2016, 30:144-54. (IF=6.319, C100)